# FDA 483 - ACTA Laboratories, Inc. - February 13, 2023

Source: https://www.globalkeysolutions.net/records/483/acta-laboratories-inc/fd8b0370-6612-4fb9-b6b4-609d11fb0cf2

> FDA 483 for ACTA Laboratories, Inc. on February 13, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ACTA Laboratories, Inc.
- Inspection Date: 2023-02-13
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [483 - 2018-01-19](https://www.globalkeysolutions.net/records/483/acta-laboratories-inc/34bf9ad5-e96f-4fe2-82d5-b9390ea689aa)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/acta-laboratories-inc/32b0e295-f8bf-4ab9-9e98-5b45ddda2d96)

## Related Officers

- [Regulatory Affairs Specialist](https://www.globalkeysolutions.net/people/andrew-le/573464c0-de29-4f64-ab33-62543b7fe719)
- [Claudia M. Perez-Kasmarski](https://www.globalkeysolutions.net/people/claudia-m-perez-kasmarski/ee989ba2-eb7a-47ae-8be5-7a28f748343b)

Company: https://www.globalkeysolutions.net/companies/acta-laboratories-inc/215a2fac-a2d0-4b2e-b8ca-8c9abe4cbb7d

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6